Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
SEK 2.14
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Dignitana AB (publ), a medical technology company, develops, produces, and markets medical cooling devices in the United States and internationally. It offers DigniCap, a scalp cooling system used to reduce hair loss from certain chemotherapy treatments, as well as in the treatment of breast cancer. The company was incorporated in 2007 is headquartered in Lund, Sweden.
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks.
Data is available to registered users only
Target Price
The average target price of DIGN.ST is 1.9 and suggests 11% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d
Data is available to registered users only
Buy
Sell